The wound dressing is designed to prevent infection and promote wound closure.
The wound contact layer of RAVIMUS VET goes on the wound and is made from natural silk nanofibers with a touch of copper and silver nanoparticles. The absorbent layer soaks up moisture and is made from eco-friendly cellulose foam.
RAVIMUS VET supports wound healing by keeping the right amount of moisture around the wound and absorbing any extra fluids.
SCIENCE BEHIND OUR TECH
We rely on the scientifically proven effectiveness of the RAVIMUS VET. Scientists and medical doctors developed Ravimus wound care technology due to 20 years of research at the National Institute of Chemical Physics and Biophysics, Estonia.
High efficacy & high safety
*In vitro cytotoxicity testing demonstrates that RavimusVet wound dressing is less toxic to human cells compared to other antibacterial dressings.
**A quantitative log reduction assay in vitro with bacterial suspension demonstrated that RavimusVet wound dressing has the highest antibacterial activity against Staphylococcus aureus.
Clinical validation
A randomized controlled trial at the North Estonian Medical Centre included 30 patients with diabetic foot ulcers. Patients were split into two groups: Group 1 received silver-based wound dressings, while Group 2 used Nanordica human advanced antibacterial dressings. Both groups were treated for 1 week with 3 dressing changes.
The study monitored wound surface area and other parameters. Results showed that wounds treated with Nanordica human dressings healed nearly twice as fast as those treated with silver-based dressings, confirming the effectiveness of the Nanordica technology.
Data from clinical study
Nanordica technology improves wound healing considerably after already 1 week of treatment.
Cu supports migration of skin cells (fibroblasts) in vitro.
Internal laboratory data (scratch assay)
OUR PUBLICATIONS
WOUND CARE ACADEMY
A paw wound bandaging video is coming soon.
A post-operative wound bandaging video is coming soon.
PATIENT'S STORIES
Sander
Aaron
ABOUT US
Most of the Nanordica scientists have pets and they have experienced the sad feeling when an animal has a wound or trauma. An animal with a wound is stressed and traumatized. To help pets recover faster and wounds heal more quickly, they created a wound dressing that minimizes trauma and rapidly repairs the wound.
Olesja Bondarenko, PhD
Chief Executive Officer
Andres Valkna, PhD
Chief Technology Officer
Meelis Kadaja, PhD, MBA
Chief Business Officer
Mart Roosimaa, MD
Medical Scientific Liaison
Grigory Vasiliev, PhD, MD
Chief Clinical Officer
The Nanordica team continues its scientific research on studying the synergistic effect of nanoparticles. We are confident that this technology will revolutionize infection control.
© 2019—2026 Nanordica Medical
Register code: 14710113
Mäealuse 2/1, Tallinn, Harjumaa 12618, Estonia